Intrahippocampal administration of an androgen receptor antagonist, flutamide, can increase anxiety-like behavior in intact and DHT-replaced male rats

Hormones and Behavior
Kassandra Edinger, Cheryl A Frye

Abstract

Testosterone (T) and its 5alpha-reduced metabolite, dihydrotestosterone (DHT), can decrease anxiety-like behavior; however, the mechanisms underlying these effects have not been established. First, we hypothesized that if T reduces anxiety-like behavior through actions of its 5alpha-reduced metabolite, DHT, then gonadectomy (GDX) would increase anxiety-like behavior, an effect which would be reversed by systemic administration of DHT. Second, we hypothesized that if T and DHT reduce anxiety-like behavior in part through actions at intracellular androgen receptors in the hippocampus, then administration of an androgen receptor antagonist, flutamide, directly to the hippocampus should increase anxiety-like behavior of intact and DHT-replaced, but not GDX, male rats. Inserts that were empty or contained flutamide were applied directly to the dorsal hippocampus of intact, GDX, or GDX and DHT-replaced rats 2 h prior to testing in the open field, elevated plus maze, or defensive freezing tasks. GDX rats exhibited significantly more anxiety-like behaviors than intact or DHT-replaced rats. Intact and DHT-replaced rats administered flutamide to the hippocampus showed significantly more anxiety-like behavior than did intact and DHT-repla...Continue Reading

References

May 1, 1992·General Pharmacology·A CaminsE Escubedo
Jan 1, 1985·Pharmacology, Biochemistry, and Behavior·D Treit
Oct 1, 1981·Pharmacology, Biochemistry, and Behavior·D TreitH C Fibiger
Dec 1, 1993·Journal of Psychosomatic Obstetrics and Gynaecology·J Nathorst-BöösK Carlström
Jun 1, 1997·Endocrinology and Metabolism Clinics of North America·T PearlsteinA B Stone
Jan 7, 1998·Neuroscience and Biobehavioral Reviews·R J Rodgers, A Dalvi
Oct 10, 1998·The American Journal of Psychiatry·H Sternbach
Oct 17, 1998·Toxicology and Applied Pharmacology·D C MorseH E Lowndes
Feb 3, 1999·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·O BingE Eriksson
Apr 15, 2000·Pharmacology, Biochemistry, and Behavior·A I SvenssonJ A Engel
Nov 4, 2000·The American Journal of Psychiatry·M A Cooper, E C Ritchie
Dec 29, 2000·Cleveland Clinic Journal of Medicine·J E Morley
Dec 7, 2002·Cognitive, Affective & Behavioral Neuroscience·C A Frye, A M Seliga
Feb 13, 2003·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Stuart N Seidman
Mar 21, 2003·Journal of Affective Disorders·Ronald C Kessler
Jul 23, 2003·Pharmacology, Biochemistry, and Behavior·Alonso Fernández-Guasti, Lucía Martínez-Mota
Aug 2, 2003·Psychoneuroendocrinology·Marie DelhezJean-Jacques Legros
Jun 12, 2004·Behavioral and Cognitive Neuroscience Reviews·Jeffrey B Rosen
Jun 29, 2004·Psychoneuroendocrinology·Cheryl A FryeJoAnna M Wawrzycki
Jul 15, 2004·Pharmacology, Biochemistry, and Behavior·Cheryl A Frye, Kassandra L Edinger
Jul 15, 2004·Pharmacology, Biochemistry, and Behavior·Kassandra L EdingerCheryl A Frye
Aug 11, 2004·Pharmacology, Biochemistry, and Behavior·Lucía Martínez-Mota, Alonso Fernández-Guasti
Apr 1, 2005·The Aging Male : the Official Journal of the International Society for the Study of the Aging Male·A Morales
May 28, 2005·Psychoneuroendocrinology·Alonso Fernández-Guasti, Lucía Martínez-Mota

❮ Previous
Next ❯

Citations

Oct 1, 2013·Frontiers in Neuroendocrinology·Jenna McHenryMohamed Kabbaj
Jul 13, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Cheryl A FryeKanako Sumida
Mar 15, 2012·Neuroendocrinology·Rebecca L CunninghamMarilyn Y McGinnis
Jun 5, 2012·Pharmacological Reports : PR·Anders I Svensson
Sep 8, 2010·Clinical Psychology Review·Patrick SylversJamie L LaPrairie
Feb 2, 2010·Behavioural Brain Research·Nobuaki EgashiraMichihiro Fujiwara
Jun 5, 2007·Physiology & Behavior·Kassandra L Edinger, Cheryl A Frye
Feb 4, 2009·Journal of Neuroendocrinology·N Goel, T L Bale
May 2, 2012·Pharmacology, Biochemistry, and Behavior·Július HodosyPeter Celec
Nov 26, 2013·Behavioural Brain Research·Dwayne K HamsonNeil V Watson
Apr 15, 2008·The International Journal of Neuropsychopharmacology·Dimitrios KouvelasMichaela M Kraus
Jul 3, 2016·Hormones and Behavior·Joseph F LynchAaron M Jasnow
Jun 19, 2016·Journal of Neuroendocrinology·A P BorrowR Yunes
Jun 4, 2017·Hormones and Behavior·Emese DomonkosPeter Celec
Apr 6, 2018·Cellular and Molecular Life Sciences : CMLS·Lisa YangWaljit S Dhillo
Aug 22, 2018·Frontiers in Endocrinology·Emese DomonkosPeter Celec
Jul 14, 2021·Environment International·Chaochen MaUNKNOWN Japan Environment Children's Study Group

❮ Previous
Next ❯

Related Concepts

Related Feeds

Amygdala: Sensory Processes

Amygdalae, nuclei clusters located in the temporal lobe of the brain, play a role in memory, emotional responses, and decision-making. Here is the latest research on sensory processes in the amygdala.

Amygdala and Midbrain Dopamine

The midbrain dopamine system is widely studied for its involvement in emotional and motivational behavior. Some of these neurons receive information from the amygdala and project throughout the cortex. When the circuit and transmission of dopamine is disrupted symptoms may present. Here is the latest research on the amygdala and midbrain dopamine.